Press releases | WebDisclosure

Basculer en Français

9752	Companies
194857	Keywords
125887	Articles
103611	Press releases

Home
Press releases

PRESS RELEASE

published on 09/17/2024 at 10:53, 1 year 4 months ago

Correction: Compagnie de l'Odet : Results in line with expectations after significant changes in scope
Compagnie de l’Odet announces first half 2024 results, conforming to expectations with significant changes in scope. Revenue of 10,591 million euros, EBITA of 611 million euros, net income of 3,869 million euros

Financial Results Revenue EBITA First Half 2024 Compagnie De L’Odet
PRESS RELEASE

published on 09/17/2024 at 10:53, 1 year 4 months ago

Correction: Compagnie de l'Odet : Résultats conformes aux attentes après d’importants mouvements de périmètre
Résultats conformes aux attentes pour le premier semestre 2024 de Compagnie de l’Odet, avec une hausse du chiffre d’affaires et du résultat net

Chiffre D’affaires Résultats Résultat Net Premier Semestre 2024 Compagnie De L’Odet
PRESS RELEASE

published on 09/17/2024 at 10:28, 1 year 4 months ago

Lancement du nouveau site web
Novacyt annonce le lancement de son nouveau site web, offrant un large portefeuille de services de diagnostic moléculaire. Visitez www.novacyt.com pour en savoir plus

Technologies Investisseurs Site Web Diagnostic Moléculaire Novacyt
PRESS RELEASE

published on 09/17/2024 at 10:26, 1 year 4 months ago

Launch of new website
Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information

Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE

published on 09/17/2024 at 10:24, 1 year 4 months ago

Information sur les résultats du 1er semestre 2024 et présentation aux investisseurs
Novacyt annonce ses résultats du 1er semestre 2024 et une présentation aux investisseurs le 26 septembre 2024. Webinaire interactif avec Lyn Rees et Steve Gibson

Résultats Semestriels Webinaire Investisseurs Diagnostic Moléculaire Novacyt
PRESS RELEASE

published on 09/17/2024 at 10:22, 1 year 4 months ago

Notice of Half Year 2024 Results and Investor Presentation
Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services

Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
PRESS RELEASE

published on 09/17/2024 at 10:00, 1 year 4 months ago

Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin
Labforward merges with LabTwin to offer expanded AI and voice-supported solutions for lab digitalization and workflow optimization, supported by Sartorius and other partners

Merger AI Sartorius Labforward LabTwin
PRESS RELEASE

published on 09/17/2024 at 09:40, 1 year 4 months ago

Proxymity and J.P. Morgan Announce the Successful Implementation of Vote Connect Total in UK and Netherlands
Proxymity's VCT service successfully implemented in the UK and Netherlands by J.P. Morgan enhances digital proxy voting, promoting accuracy, transparency, and efficiency in investor relations globally

Investor Relations Proxymity Digital Proxy Voting J.P. Morgan VCT Service
PRESS RELEASE

published on 09/17/2024 at 09:14, 1 year 4 months ago

ELARIS AG posts its first positive operating result in the first half of 2024 and grows dynamically
ELARIS AG achieves its first positive operating result in the first half of 2024, with sales revenues growing dynamically and significant further growth expected for the full year

2024 Growth ELARIS AG Sales Revenues Positive Operating Result
PRESS RELEASE

published on 09/17/2024 at 09:02, 1 year 4 months ago

Original-Research: Rubean AG (von NuWays AG): BUY
NuWays AG releases updated research on Rubean AG, highlighting successful product roll-out, strong pipeline with major customer wins expected, and significant market potential in mPOS space

NuWays AG Rubean AG Product Roll-out Customer Wins MPOS Market

Accesswire

Published on 01/27/2026 at 14:15, 12 minutes ago

Terravis Energy Secures Mass Manufacturing for No-Defrost Heat Pump Amid North American Polar Vortex Crisis
Published on 01/27/2026 at 14:00, 27 minutes ago

Temas Strengthens Board to Support Growth Strategy and Critical Minerals Advancement
Published on 01/27/2026 at 13:45, 42 minutes ago

Silver X Mining Launches Brokered Private Placement of Up To C$60M in Convertible Debentures
Published on 01/27/2026 at 13:30, 57 minutes ago

Alset AI's Lyken.AI Approved as Vendor from Leading Multinational Technology and Telecommunications Company
Published on 01/27/2026 at 13:30, 57 minutes ago

Lahontan Drills More Shallow Oxide Gold at Slab: 69m Grading 0.45 g/t Au Eq Including 17m Grading 0.81 g/t Au Eq

View all ACCESSWIRE

EQS Group

Published on 01/27/2026 at 14:05, 22 minutes ago

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Published on 01/27/2026 at 13:55, 32 minutes ago

RoboMarkets expands access to over 1,400 XETRA-traded stocks and ETFs
Published on 01/27/2026 at 13:55, 32 minutes ago

Phemex Introduces Elite Trader Recruitment Program Focused on Professional Copy Trading
Published on 01/27/2026 at 13:30, 57 minutes ago

Infosys and Cursor announce Strategic Collaboration to Accelerate Software Engineering for Global Enterprises
Published on 01/27/2026 at 13:14, 1 hour 12 minutes ago

innoscripta SE publishes Preliminary Annual Results for 2025

Les Echos

Published on 01/27/2026 at 14:05, 22 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167296
Published on 01/27/2026 at 14:05, 22 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010167296
Published on 01/27/2026 at 14:01, 25 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167247
Published on 01/27/2026 at 14:01, 25 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010167247
Published on 01/27/2026 at 12:44, 1 hour 43 minutes ago

Déclaration des transactions sur actions propres réalisées du 19/01/2026 au 23/01/2026

View all LES ECHOS COMFI WIRE